Biomarkers · Hematology

Monocyte Count

Lower values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).

Monocyte Count and risk of death

Published curve higher than the NHANES fitNHANES fit higher

Risk of death relative to the curve's reference value, drawn from the published study (source below).

Published risk of death1.13×per 0.1x10^9/L increase in monocyte count (95% CI 1.06–1.19) · Danish men and women aged 55-75 free of known cancer or cardiovascular disease (n=669), Copenhagen

Monocyte Count by age and sex

Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.

The percentiles as a table

Each row is one sex and age band: the values below which 5%, 25%, 50%, 75% and 95% of people fall (10^3 cells/uL), from the survey named in the row. Not a reference range or a target.
Sex	Age	5th	25th	Median	75th	95th	n	Cycle / source
All	20-39	0.30	0.50	0.60	0.70	0.90	1,456	NHANES 2017-2018
All	40-59	0.30	0.40	0.50	0.70	0.90	1,582	NHANES 2017-2018
All	60+	0.30	0.50	0.60	0.70	1.00	1,939	NHANES 2017-2018
All	all	0.30	0.50	0.60	0.70	0.90	4,977	NHANES 2017-2018
Men	20-39	0.30	0.50	0.60	0.70	1.00	698	NHANES 2017-2018
Men	40-59	0.30	0.50	0.60	0.70	0.90	740	NHANES 2017-2018
Men	60+	0.40	0.50	0.60	0.70	1.00	981	NHANES 2017-2018
Men	all	0.30	0.50	0.60	0.70	1.00	2,419	NHANES 2017-2018
Women	20-39	0.30	0.40	0.50	0.60	0.90	758	NHANES 2017-2018
Women	40-59	0.30	0.40	0.50	0.60	0.80	842	NHANES 2017-2018
Women	60+	0.30	0.40	0.60	0.70	0.90	958	NHANES 2017-2018
Women	all	0.30	0.40	0.50	0.70	0.90	2,558	NHANES 2017-2018

Sources

Risk curve: Sajadieh A 2011 (PMID 21439818): all-cause HR 1.13 (1.06-1.19) per 0.1x10^9/L increase in monocyte count. Scaled to US values (NHANES).
Sajadieh A, Mouridsen MR, Selmer C, Intzilakis T, Nielsen OW, Haugaard SB. Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes. Eur J Cancer. 2011;47(13):2015-22.

Map Monocyte Count against another biomarker.

Map Monocyte Count against another marker